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250* Can physiological parameters determine the optimal method of
airway clearance for the individual patient with cystic ﬁbosis?
P.M. McIlwaine1,2, A.G. Davidson1, Y. Lillquist1, D. Peacock1. 1Cystic Fibrosis,
BC Children’s Hospital, Vancouver, BC, Canada; 2Physiotherapy, BC Children’s
Hospital, Vancouver, BC, Canada
Introduction: CF patients frequently express preferences for one airway clearance
technique (ACT) over another and may be able to clear more secretions with that
technique. Expiratory airﬂow is utilized by modern ACT’s to mobilize secretions,
yet only one study has examined the effect of various ACTs on Peak expiratory
ﬂow rates (PEFR).
Aim: The purpose of this study was to determine whether there exists different
individual responses to ACTs as measured by PEFR which are dependent on the
individual’s underlying lung pathology.
Method: Maximum expiratory ﬂow volume maneuvers were obtained from CF
patients and categorized according to type and severity of lung disease. In addition
to measuring FVC, FEV1 and FEF25/75, PEFR, PIFR, FIV1 were examined to
determine the degree of airway compression and ﬂow rates. Patients then repeated
their ﬂow volume loops while performing a component of an ACT. The ACT
components used were a forceful huff, a gentle huff, and autogenic drainage
breathing.
Results varied greatly among patients. In patients whose PFTs suggested compress-
ible large airways PEFR was greatest with AD > gentle huff > forceful huff. Only
AD had a PEFR/PIFR greater than 1.1 which is needed for secretion clearance by
annular ﬂow. AD produced the greatest amount of sputum in these patients.
In patients with mild lung disease, PEFR was greatest with a forceful huff > gentle
huff > AD.
Conclusions: No one ACT produced consistently greater PEFRs, instead they were
dependent on the underlying lung pathology. In prescribing an ACT, it may be
useful to use pulmonary function ﬂow volume maneuvers to assist in determining
the most effective technique for the individual patient
251 A retrospective analysis of various airways clearance techniques
on FEV1 decline over one year in cystic ﬁbrosis patients
R.C. Mills, A.L. Stokes, L. Speight, R.I. Ketchell. Cystic Fibrosis, Llandough
Hospital, Penarth, United Kingdom
Background: The Cochrane review (van der Schans, 2000) has been unable to
demonstrate the efﬁcacy of any airways clearance technique (ACT) in the long-
term treatment of Cystic Fibrosis (CF).
Aim: To retrospectively evaluate the effect various ACTs on FEV 1 decline of over
1 year.
Method: A retrospective analysis of 124 CF patients (Male = 68, Female = 56,
mean age = 27.8 years) was conducted. Patients were grouped according to
ACT performed with greater than 40% compliance (self-reported). Data was also
collected in those patients with poor compliance. FEV1 decline over one year
was the primary outcome measure. Groups were also analysed regarding baseline
demographics including; diabetic and infection status, age, gender, baseline FEV1
and Body mass index (BMI).
Results: Baseline demographic data revealed no statistically signiﬁcant differences
between any group including the non-compliant group (p = 0.05). No statistically
signiﬁcant difference was seen between any ACT including the non-compliant group
after one year (p = 0.05). However, a trend was suggestive of a lower decline in FEV1
in the Positive Expiratory Pressure (PEP) group (−0.4% n= 45) compared with the
non-compliant group (−2.2% n= 38); the percussion and vibration group (−3.3%
n= 20); ACBT group (−3.% n= 15) and the exercise alone group (−0.75% n= 6).
Conclusion: These ﬁndings concur with those of the Cochrane review (van der
Schans, 2000) that suggest there is no evidence supporting one ACT over another
in the long-term treatment of CF patients.
252 High frequency chest wall oscillation: an adjunct to other airway
clearance techniques in CF adults?
L. Gumery1, J. Barrett1, A. Kailey1, D. Honeybourne1, J. Whitehouse1, J. Lee1,
L. Kenyon1, S. Ledbetter1. 1. West Midlands Regional CF Centre, Birmingham,
United Kingdom.
Aim: To audit the use of high frequency chest wall oscillation (HFCWO) in
addition to usual airway clearance techniques (ACT), heighten awareness, promote
discussion and enhance it’s consideration as a Rx adjunct.
Method: Audit was undertaken of 11 Rx episodes in 10 CF adults (7M:3F, age
19−46 yrs). Data collected included demographics, lung disease severity, ACT
utilised, O2 saturation (SPO2), heart rate (HR) and adverse events. Outcomes
included FEV1% predicted, sputum wet weight and patient satisfaction. HFCWO
was utilised in addition to the usual ACT of ACBT (5/10) and AD with/without
Acapella/Flutter/PEP/IPPB (5/10).
Results: 9/11 Rx episodes (range 7−36 days, mean 19 days) of HFCWO and usual
ACT were completed. 2 adults discontinued HFCWO due to nausea/didn’t like it.
No adverse effect or change in SpO2 (range 91−99%, mean 95%) or HR (range
66–123 bpm, mean 85 bpm) was noted. FEV1% predicted increased (start range
11−91%, mean 37%) to (range 12–102%, mean 46%) at end of Rx episode. This
represented an increased FEV1%/patient of 1−20%, mean increase 8%, comparable
to ACT alone. Sputum weight voided/day was greater than with ACT alone, during
Rx sessions (range 0–102 g, mean 23 g), outside Rx (range 0–174 g, mean 51 g)
and total/day (range 8–276 g, mean 106 g). 8/10 adults reported ‘improved mucus
clearance’ ‘more effective than ACT alone’ and ‘wish to use again’.
Conclusion: HFCWO in addition to usual ACT was well tolerated and patient sat-
isfaction high. FEV1 and sputum weight outcomes were not signiﬁcantly increased
compared to ACT alone. This audit heightened awareness, promoted discussion and
enhanced consideration of HFCWO in addition to usual ACT. Further study is being
undertaken to evaluate beneﬁt.
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Little is known about the efﬁcacy of airway clearance (AC) techniques used
following lung transplant (LT). This study aimed to compare the effects of two
AC strategies (proactive vs reactive) on a range of clinical outcomes following LT.
Methods: A prospective randomized trial design with stratiﬁcation for suppurative
pre-LT disease was used. Consecutive patients at 1 month post LT were eligible for
inclusion. Subjects were excluded if medically unstable, ventilator dependent or had
a contraindication to performing positive expiratory pressure (PEP) therapy. Patients
performed AC using PEP either twice daily (proactive strategy) or only in the
presence chest infection (reactive strategy). Lung function (FEV1 and FVC), chest
radiography (Brasﬁeld score), exercise capacity (6 minute walk) and bronchoscopic
airway characteristics (anastomotic healing, patency and secretions) were assessed
at 1, 2 and 3 months post LT. Adherence and satisfaction were measured.
Results: Of 60 consecutive patients, 36 (18 in each group) were recruited and
completed the study. Both groups improved lung function (FEV1 72±4% to 81±4%
p< 0.0001; FVC 69±3% to 81±3% p< 0.0001), Brasﬁeld scores (17.8±0.5 to
19.8±0.5 p< 0.002) and 6 minute walk (451±16m to 545±16m p< 0.0001) over
the study period. No signiﬁcant differences between groups for any outcome were
found. Adherence to both strategies was high (>84%). The reactive strategy was
preferred.
Conclusion: In the absence of signiﬁcant differences in outcomes, it is recom-
mended that AC only be performed in the presence of chest infection.
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